{
  "symbol": "IMDX",
  "company": "Insight Molecular Diagnostics Inc.",
  "generated_at": "2026-06-24T07:36:48.804Z",
  "event_count": 3,
  "events": [
    {
      "type": "pipeline_event",
      "ts": "2026-06-16T00:53:28.681Z",
      "stage": "analyst",
      "outcome": "skip",
      "reason": "Score falls well below the 45 threshold. Three anti-signal gates trigger: dilution risk from warrants and repeated capital raises, extreme concentration with Broadwood holding ~39%, and low liquidity that makes executing the only viable structure (income) impractical without severe slippage. The single concentrated buyer does not form a smart-money cluster, and the FDA catalyst remains too distant and unpriced for a recommendation-grade setup.",
      "trigger": "[insider_cluster_universe] 3 Form 4 filings in last 14 days · at least one open-market P/S trade verified",
      "source": "idle_hunter"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-06-16T00:53:28.662Z",
      "skip": true,
      "reason": "Score falls well below the 45 threshold. Three anti-signal gates trigger: dilution risk from warrants and repeated capital raises, extreme concentration with Broadwood holding ~39%, and low liquidity that makes executing the only viable structure (income) impractical without severe slippage. The single concentrated buyer does not form a smart-money cluster, and the FDA catalyst remains too distant and unpriced for a recommendation-grade setup.",
      "score": 17,
      "breakdown": {
        "smart_money": 2,
        "options_flow": 0,
        "catalyst": 5,
        "mispricing": 5,
        "quality": 0,
        "technical": 5
      },
      "debug_path": "drafts/2026-06-16-IMDX.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-06-16T00:52:50.057Z",
      "summary": "Insight Molecular Diagnostics (Nasdaq: IMDX) is a pre-commercial precision diagnostics company centered on GraftAssure, a dd-cfDNA blood test for transplant rejection monitoring. The investigation triggered on Form 4 cluster activity — three June 11/15 filings turned out to be RSU vesting events (no-cost acquisitions at $0), not open-market purchases. However, a separate and more meaningful signal exists: Broadwood Partners LP, the company's largest shareholder (~39% of shares) and a board-connected entity, executed ~753k shares of open-market purchases in April 2026 alone across six trading days at weighted-average prices of $3.44–$3.88/share (~$2.7M total), followed by additional filings bringing their position to over 12.68M shares directly owned. The company submitted GraftAssureDx for FDA review on March 25, 2026 and expects UK CE marking via self-certification imminently in Q2 2026. Multiple peer-reviewed publications (American Journal of Transplantation, EFI, ERA, ATC) are creating data momentum heading into the American Transplant Congress in Boston June 20–24. The stock trades at $5.70 with a $184M market cap vs. analyst price targets of $8.33 (mean FV estimate) to $12 (upside scenario).",
      "verdict": "range_bound_or_income",
      "confidence": 4,
      "tool_calls": 21,
      "walltime_min": 15,
      "debug_path": "dossiers/2026-06-16-IMDX.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "IMDX",
    "call": "HOLD",
    "confidence": 1,
    "score": 1,
    "factors": {
      "above_200dma": "+2",
      "above_50dma": "+1",
      "momentum_strong_up": "+2 (70.4%)",
      "rsi_neutral": "0 (47.3)",
      "recent_macd_bearish_cross": "-2 (14d ago)",
      "broken_below_high": "-2 (-36.7% from high)"
    },
    "summary": "HOLD (score +1) · 12-1 mom 70.4% · RSI 47.3 · above_both · -36.7% from high",
    "last_close": 5.37,
    "one_month_ago_close": 5.88,
    "twelve_month_ago_close": 3.45,
    "twelve_one_momentum_pct": 70.43,
    "rsi_14": 47.3,
    "ma_stack": "above_both",
    "from_period_high_pct": -36.67,
    "period_high": 8.48,
    "price_targets": {
      "bear": 4,
      "fair": 6.27,
      "bull": 12,
      "bear_return_pct": -25.5,
      "fair_return_pct": 16.7,
      "bull_return_pct": 123.5,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 4,
        "target_mean": 8.33333,
        "target_high": 12,
        "analyst_count": 3
      }
    },
    "generated_at": "2026-06-24T07:36:48.799Z"
  }
}